Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124549793 | 12454979 | 3 | F | 20160329 | 20160627 | 20160610 | 20160705 | PER | US-PFIZER INC-2016286420 | PFIZER | 71.00 | YR | M | Y | 86.00000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124549793 | 12454979 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | Y | 20702 | 10 | MG | FILM-COATED TABLET | QD | |||||
| 124549793 | 12454979 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Y | 20702 | FILM-COATED TABLET | ||||||||||
| 124549793 | 12454979 | 3 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | Y | M26606 | 20702 | 10 | MG | FILM-COATED TABLET | QD | ||||
| 124549793 | 12454979 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124549793 | 12454979 | 1 | Blood cholesterol |
| 124549793 | 12454979 | 2 | Hyperlipidaemia |
| 124549793 | 12454979 | 3 | Blood cholesterol |
| 124549793 | 12454979 | 4 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124549793 | 12454979 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124549793 | 12454979 | Blood creatine phosphokinase increased | |
| 124549793 | 12454979 | Joint stiffness | |
| 124549793 | 12454979 | Movement disorder | |
| 124549793 | 12454979 | Muscular weakness | |
| 124549793 | 12454979 | Myopathy | |
| 124549793 | 12454979 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124549793 | 12454979 | 3 | 20160329 | 20160426 | 0 |